Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
about
Response to radiation in renal medullary carcinomaRenal medullary carcinoma: a case report and brief review of the literature.Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapyNon-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?Renal Medullary Carcinoma with an Aggressive Clinical Course: A Case Report and Review of the Literature.Renal medullary carcinoma and sickle cell trait: A systematic review.Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy.Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.Renal medullary carcinoma with an ophthalmic metastasis.Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.Expression of Topoisomerase II-α protein in salivary gland tumors.Management of Atypical Renal Cell Carcinomas.Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition.Renal medullary carcinoma: A national analysis of 159 patients.Imaging of Renal Medullary Carcinoma.SMARCB1/INI1 inactivation in renal medullary carcinoma.
P2860
Q24631765-83A54C5F-638D-4C57-9516-B925DB83B47BQ33737547-FB21AD4E-87AC-4AE9-8A19-60C2B0A1886CQ34145962-F7B654A6-9562-474F-8CFE-1291D655E460Q34194075-30DB3E04-2835-4DBD-881E-524F489473B6Q34206531-25DA85E7-0C79-45CD-867A-3DE8D9208759Q35155611-147D8668-43FF-4776-8F44-58C52552E9ADQ37634874-3B5FEBBA-DAFE-466B-B4CA-B8B0C2564622Q38520332-5904643E-EB90-471F-9D69-D05AD09A100CQ38611497-0C5BAA8A-8D50-46D1-B190-CB01A94FDF06Q39176728-4C436911-98CA-462C-831F-2678C8820CCCQ39289507-3D897703-DDC9-45C7-ACC3-F59339A25863Q41835725-0CD65615-1B57-4A2E-A809-E485EFC6504AQ42939114-A62595F6-B9BB-445A-B411-E6942F3CFFA3Q43068064-A9BBE7ED-0EA9-48B1-8322-890A9393D9FAQ47147047-FEF85663-1B58-42E3-908B-303A1154E8AFQ47947817-659911C0-1105-45E3-B024-94D517301B47Q49355768-CF834728-BB0E-4063-BA2C-456BBFD1CE05Q50662149-E1929634-E475-4A28-A9AB-4151C853D3DDQ53733661-27485F45-4F76-46A3-932B-EEF3C74432F9Q54305674-BFAF4EB4-4B2C-4F9E-A84B-432C677FF989
P2860
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Renal medullary carcinoma: mol ...... oisomerase-inhibiting therapy.
@en
type
label
Renal medullary carcinoma: mol ...... oisomerase-inhibiting therapy.
@en
prefLabel
Renal medullary carcinoma: mol ...... oisomerase-inhibiting therapy.
@en
P2093
P1433
P1476
Renal medullary carcinoma: mol ...... oisomerase-inhibiting therapy.
@en
P2093
Christian P Pavlovich
George Netto
Karl Dykema
Kyle A Furge
Michael Westphal
Thomas J Guzzo
Ximing Yang
P356
10.1111/J.1464-410X.2009.09139.X
P577
2009-12-11T00:00:00Z